JPH043505B2 - - Google Patents
Info
- Publication number
- JPH043505B2 JPH043505B2 JP58167351A JP16735183A JPH043505B2 JP H043505 B2 JPH043505 B2 JP H043505B2 JP 58167351 A JP58167351 A JP 58167351A JP 16735183 A JP16735183 A JP 16735183A JP H043505 B2 JPH043505 B2 JP H043505B2
- Authority
- JP
- Japan
- Prior art keywords
- time
- electrical signal
- partial thromboplastin
- plasma
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108010000499 Thromboplastin Proteins 0.000 claims description 27
- 102000002262 Thromboplastin Human genes 0.000 claims description 27
- 239000003153 chemical reaction reagent Substances 0.000 claims description 27
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 claims description 25
- 108010049003 Fibrinogen Proteins 0.000 claims description 23
- 102000008946 Fibrinogen Human genes 0.000 claims description 23
- 229940012952 fibrinogen Drugs 0.000 claims description 23
- 230000015271 coagulation Effects 0.000 claims description 19
- 238000005345 coagulation Methods 0.000 claims description 19
- 108010094028 Prothrombin Proteins 0.000 claims description 18
- 102100027378 Prothrombin Human genes 0.000 claims description 18
- 229940039716 prothrombin Drugs 0.000 claims description 18
- 230000008859 change Effects 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 230000023555 blood coagulation Effects 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims 1
- 238000005259 measurement Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16735183A JPS6058555A (ja) | 1983-09-09 | 1983-09-09 | 血液凝固測定方法および測定装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16735183A JPS6058555A (ja) | 1983-09-09 | 1983-09-09 | 血液凝固測定方法および測定装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6058555A JPS6058555A (ja) | 1985-04-04 |
JPH043505B2 true JPH043505B2 (de) | 1992-01-23 |
Family
ID=15848113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16735183A Granted JPS6058555A (ja) | 1983-09-09 | 1983-09-09 | 血液凝固測定方法および測定装置 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6058555A (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2610434B2 (ja) * | 1987-06-05 | 1997-05-14 | 株式会社 京都第一科学 | 血液凝固能測定方法 |
JP2994557B2 (ja) | 1994-09-02 | 1999-12-27 | 株式会社アズウェル | フィブリノゲン測定方法およびその測定試薬 |
JP4858092B2 (ja) | 2006-11-07 | 2012-01-18 | アイシン精機株式会社 | 車両用ステップ装置 |
JP4957523B2 (ja) * | 2007-11-22 | 2012-06-20 | アイシン精機株式会社 | 車両用ステップ装置 |
JP5312835B2 (ja) * | 2008-03-31 | 2013-10-09 | シスメックス株式会社 | 血液凝固分析装置、血液凝固分析方法、及びコンピュータプログラム |
JP5312834B2 (ja) * | 2008-03-31 | 2013-10-09 | シスメックス株式会社 | 血液凝固分析装置、血液凝固分析方法、及び、コンピュータプログラム |
WO2009122993A1 (ja) | 2008-03-31 | 2009-10-08 | シスメックス株式会社 | 血液凝固分析装置、血液凝固分析方法、及びコンピュータプログラム |
JP7191613B2 (ja) * | 2018-09-26 | 2022-12-19 | キヤノンメディカルシステムズ株式会社 | 血液凝固分析装置 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5467496A (en) * | 1977-11-09 | 1979-05-30 | Itoman Kk | Device for measuring solidification of blood plasma |
JPS5469497A (en) * | 1977-11-12 | 1979-06-04 | Kyoto Daiichi Kagaku Kk | Method and device for measuring blood solidification time |
JPS56129843A (en) * | 1980-02-16 | 1981-10-12 | Compur Electronic Gmbh | Photometric method of and apparatus for measuring progress of reaction |
JPS56140240A (en) * | 1980-04-04 | 1981-11-02 | Hitachi Ltd | Photometer for blood coagulation measurement |
JPS5730954A (en) * | 1980-08-01 | 1982-02-19 | Hitachi Ltd | Measuring device for blood coagulation |
-
1983
- 1983-09-09 JP JP16735183A patent/JPS6058555A/ja active Granted
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5467496A (en) * | 1977-11-09 | 1979-05-30 | Itoman Kk | Device for measuring solidification of blood plasma |
JPS5469497A (en) * | 1977-11-12 | 1979-06-04 | Kyoto Daiichi Kagaku Kk | Method and device for measuring blood solidification time |
JPS56129843A (en) * | 1980-02-16 | 1981-10-12 | Compur Electronic Gmbh | Photometric method of and apparatus for measuring progress of reaction |
JPS56140240A (en) * | 1980-04-04 | 1981-11-02 | Hitachi Ltd | Photometer for blood coagulation measurement |
JPS5730954A (en) * | 1980-08-01 | 1982-02-19 | Hitachi Ltd | Measuring device for blood coagulation |
Also Published As
Publication number | Publication date |
---|---|
JPS6058555A (ja) | 1985-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4252536A (en) | Method and system for measuring blood coagulation time | |
US4047890A (en) | Method and apparatus for determining deficiencies in enzymatic reactors particularly clotting factor levels in blood plasmas | |
US6069011A (en) | Method for determining the application of a sample fluid on an analyte strip using first and second derivatives | |
US20060035298A1 (en) | System and method for determining a coagulation parameter | |
JPH08502590A (ja) | 差込可能メモリーキーを伴うバイオセンシングメータ | |
US5156974A (en) | Method for determining the fibrinogen level of a blood sample | |
JPH043505B2 (de) | ||
JP5029638B2 (ja) | 血液凝固分析装置 | |
JP6692361B2 (ja) | 自動分析装置、自動分析システム及び自動分析方法 | |
CN104854459A (zh) | 自动分析装置 | |
US7817255B2 (en) | Apparatus with a combination of a point light source and a single lens | |
Karon et al. | Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers | |
US4454752A (en) | Test circuit for use in coagulation instrument | |
KR101205098B1 (ko) | 엘이디 컬러 센서를 이용한 자동 중화 적정 장치 및 방법 | |
JPH0334592B2 (de) | ||
JP2610434B2 (ja) | 血液凝固能測定方法 | |
JPH10123140A (ja) | 血液凝固測定装置 | |
CN111272678A (zh) | 一种样本检测方法、凝血分析仪及存储介质 | |
EP0010526B1 (de) | Verfahren und Vorrichtung zur Untersuchung der Blutkoagulation oder der Aggregation von Blutplättchen | |
US20040219680A1 (en) | Method and apparatus for determining anticoagulant therapy factors | |
JPS58172537A (ja) | 光散乱測定装置 | |
CA1062501A (en) | Method and apparatus for determining deficiencies in enzymatic reactions particularly clotting factor levels in blood plasma | |
TW201113522A (en) | Microchip blood analyzer | |
JPS6168539A (ja) | 生化学測定装置 | |
JPH04318463A (ja) | 血液凝固時間の測定方法 |